Stock Research: Cogent Biosciences

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Cogent Biosciences

NSQ:COGT US19240Q2012
58
  • Value
    74
  • Growth
    54
  • Safety
    Safety
    13
  • Combined
    48
  • Sentiment
    73
  • 360° View
    360° View
    58
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

ANALYSIS: With an Obermatt 360° View of 46 (better than 46% compared with alternatives), overall professional sentiment and financial characteristics for the stock Cogent Biosciences are below the industry average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Cogent Biosciences. The consolidated Value Rank has an attractive rank of 73, which means that the share price of Cogent Biosciences is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 73% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 55, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 69. But the company’s financing is risky with a Safety rank of 13. This means 87% of comparable companies have a safer financing structure than Cogent Biosciences. ...read more

more
Index
NASDAQ
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 8-Jun-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
74 n/a n/a n/a
Growth
54 n/a n/a n/a
Safety
Safety
13 n/a n/a n/a
Sentiment
73 n/a n/a n/a
360° View
360° View
58 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
19 n/a n/a n/a
Opinions Change
50 n/a n/a n/a
Pro Holdings
n/a n/a n/a n/a
Market Pulse
72 n/a n/a n/a
Sentiment
73 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
74 n/a n/a n/a
Growth
54 n/a n/a n/a
Safety Safety
13 n/a n/a n/a
Combined
48 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
41 n/a n/a n/a
Price vs. Earnings (P/E)
84 n/a n/a n/a
Price vs. Book (P/B)
9 n/a n/a n/a
Dividend Yield
n/a n/a n/a n/a
Value
74 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
91 n/a n/a n/a
Profit Growth
8 n/a n/a n/a
Capital Growth
55 n/a n/a n/a
Stock Returns
92 n/a n/a n/a
Growth
54 n/a n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
15 n/a n/a n/a
Refinancing
49 n/a n/a n/a
Liquidity
31 n/a n/a n/a
Safety Safety
13 n/a n/a n/a

Similar Stocks

Discover high‑ranked alternatives to Cogent Biosciences and broaden your portfolio horizons.

Aramark

NYQ:ARMK
Country: USA
Industry: Restaurants
Size: X-Large
Full Stock Analysis

Penske Automotive

NYQ:PAG
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

VSE

NSQ:VSEC
Country: USA
Industry: Aerospace & Defense
Size: Medium
Full Stock Analysis

Western Alliance Bank

NYQ:WAL
Country: USA
Industry: Regional Banks
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is a high-quality, high-growth stock with positive sentiment. However, the financing is on the riskier side. It is best for a growth-focused investor willing to accept higher financial risk for potentially higher shareholder returns.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: